Gentry Private Wealth LLC Sells 66 Shares of The Procter & Gamble Company (NYSE:PG)

Gentry Private Wealth LLC cut its stake in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 2.6% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,501 shares of the company’s stock after selling 66 shares during the quarter. Gentry Private Wealth LLC’s holdings in Procter & Gamble were worth $433,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Daiwa Securities Group Inc. lifted its holdings in Procter & Gamble by 3.7% in the 3rd quarter. Daiwa Securities Group Inc. now owns 383,840 shares of the company’s stock worth $66,481,000 after purchasing an additional 13,576 shares in the last quarter. Marco Investment Management LLC lifted its holdings in Procter & Gamble by 1.3% in the 3rd quarter. Marco Investment Management LLC now owns 61,490 shares of the company’s stock worth $10,650,000 after purchasing an additional 800 shares in the last quarter. Summit Trail Advisors LLC lifted its holdings in Procter & Gamble by 35.6% in the 3rd quarter. Summit Trail Advisors LLC now owns 18,852 shares of the company’s stock worth $3,265,000 after purchasing an additional 4,952 shares in the last quarter. Cahill Financial Advisors Inc. lifted its holdings in Procter & Gamble by 3.8% in the 3rd quarter. Cahill Financial Advisors Inc. now owns 2,359 shares of the company’s stock worth $409,000 after purchasing an additional 87 shares in the last quarter. Finally, SevenBridge Financial Group LLC lifted its holdings in Procter & Gamble by 5.4% in the 3rd quarter. SevenBridge Financial Group LLC now owns 30,989 shares of the company’s stock worth $5,145,000 after purchasing an additional 1,579 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors.

Procter & Gamble Stock Performance

Shares of Procter & Gamble stock opened at $176.28 on Friday. The stock’s fifty day moving average is $170.04 and its two-hundred day moving average is $168.64. The company has a market capitalization of $415.15 billion, a PE ratio of 30.39, a price-to-earnings-growth ratio of 3.74 and a beta of 0.42. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The Procter & Gamble Company has a 52 week low of $142.50 and a 52 week high of $177.94.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings data on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.90 by $0.03. The company had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. Procter & Gamble’s quarterly revenue was down .6% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.83 EPS. As a group, analysts expect that The Procter & Gamble Company will post 6.94 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were given a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.28%. The ex-dividend date was Friday, October 18th. Procter & Gamble’s payout ratio is 69.48%.

Analyst Ratings Changes

A number of research analysts recently commented on the company. Piper Sandler assumed coverage on Procter & Gamble in a report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price target on the stock. Wolfe Research raised Procter & Gamble to a “strong-buy” rating in a report on Friday, August 23rd. JPMorgan Chase & Co. upped their price objective on Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a report on Thursday, September 19th. Evercore ISI upped their price objective on Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a report on Monday, October 21st. Finally, Hsbc Global Res raised Procter & Gamble to a “strong-buy” rating in a report on Friday, October 4th. Nine analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $178.00.

Check Out Our Latest Stock Analysis on Procter & Gamble

Insider Transactions at Procter & Gamble

In other news, insider Balaji Purushothaman sold 12,800 shares of the stock in a transaction on Thursday, October 24th. The stock was sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the transaction, the insider now owns 11,566 shares of the company’s stock, valued at approximately $1,954,538.34. This represents a 52.53 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Susan Street Whaley sold 634 shares of the stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total value of $108,826.10. Following the transaction, the insider now directly owns 19,341 shares in the company, valued at $3,319,882.65. The trade was a 3.17 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 160,693 shares of company stock valued at $27,311,345. 0.18% of the stock is currently owned by corporate insiders.

About Procter & Gamble

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.